Origent Data Sciences, Inc. is dedicated to managing and reducing drug development risks through better foresight. We are experts in the development and application of predictive models that are designed to anticipate and predict the dynamics of individual patients. By modeling patient-level dynamics (rather than modeling the characteristics of a population), our models uncover a deeper level of insight, one that allows biostatisticians and researchers to gain clearer understanding and greater knowledge from their data. Rather than considering similar patients to act the same as one another, we treat and model each individual patient separately, and predict their behavior individually. We then use this information to conduct in-depth comparisons and analyses of observed clinical data for each patient. Origent provides predictive intelligence to pharmaceutical and biotech companies, helping them make early decisions to manage their drug development pipelines. Origent also supports venture capitalists and angel investors in their due diligence of prospective biotech investments, by simulating clinical trials and placebo controls to determine whether the next human clinical trials will likely succeed or fail.